Aquestive Therapeutics Inc Cash Flow Reinvestment Rate

Latest as of March 2023: 0.00x

Aquestive Therapeutics Inc cash flow reinvestment rate. Aquestive Therapeutics Inc (AQST) has a Cash Flow Reinvestment Rate of 0.00x as of March 2023, reinvesting $4.00K (capex $2.00K plus investments $-2.00K) from operating cash flow of $8.82 Million. Explore Aquestive Therapeutics Inc (AQST) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.

Reinvestment Rate

0.00x

(Capex + Investments) / Operating CF

Total Reinvested

$4.00K

Capex + Investments

Operating Cash Flow

$8.82 Million

USD

Capital Expenditures

$2.00K

USD

Cash Flow Reinvestment Rate of Aquestive Therapeutics Inc (2017–2017)

Cash flow reinvestment rate of Aquestive Therapeutics Inc from 2017 to 2017. Historical reinvestment intensity for Aquestive Therapeutics Inc across 1 annual periods. Explore Aquestive Therapeutics Inc (AQST) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.

Aquestive Therapeutics Inc Cash Flow Reinvestment Rate by Year (2017–2017)

Aquestive Therapeutics Inc cash flow reinvestment rate by year from 2017 to 2017. Year-by-year capital reinvestment analysis for Aquestive Therapeutics Inc. For the full cash flow conversion analysis, see Aquestive Therapeutics Inc cash flow conversion.

Year	Reinvestment Rate	Total Reinvested (USD)	Operating CF	Capex	YoY Change
2017	0.71x	$4.14 Million	$5.82 Million	$2.07 Million	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow